151 related articles for article (PubMed ID: 34802014)
1. TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes.
Lamture G; Baer A; Fischer JW; Colon-Moran W; Bhattarai N
J Immunother; 2022 Apr; 45(3):139-149. PubMed ID: 34802014
[TBL] [Abstract][Full Text] [Related]
2. Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19
Teoh J; Brown LF
Cytotherapy; 2022 Sep; 24(9):962-973. PubMed ID: 35610089
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control.
Cai Y; Prochazkova M; Jiang C; Song HW; Jin J; Moses L; Gkitsas N; Somerville RP; Highfill SL; Panch S; Stroncek DF; Jin P
J Transl Med; 2021 Dec; 19(1):523. PubMed ID: 34952597
[TBL] [Abstract][Full Text] [Related]
4. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
[TBL] [Abstract][Full Text] [Related]
5. CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products.
Kath J; Du W; Martini S; Elsallab M; Franke C; Hartmann L; Drosdek V; Glaser V; Stein M; Schmueck-Henneresse M; Reinke P; Volk HD; Abou-El-Enein M; Wagner DL
Blood Adv; 2023 Aug; 7(15):4124-4134. PubMed ID: 37196643
[TBL] [Abstract][Full Text] [Related]
6. Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell Therapy.
Michaux A; Mauën S; Breman E; Dheur MS; Twyffels L; Saerens L; Jacques-Hespel C; Gauthy E; Agaugué S; Gilham DE; Sotiropoulou PA
J Immunother; 2022 Apr; 45(3):150-161. PubMed ID: 35191428
[TBL] [Abstract][Full Text] [Related]
7. Release Assays and Potency Assays for CAR T-Cell Interventions.
Dias J; Cadiñanos-Garai A; Roddie C
Adv Exp Med Biol; 2023; 1420():117-137. PubMed ID: 37258787
[TBL] [Abstract][Full Text] [Related]
8. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics.
Cheng J; Zhao Y; Hu H; Tang L; Zeng Y; Deng X; Ding S; Guo AY; Li Q; Zhu X
Cancer Immunol Immunother; 2023 Oct; 72(10):3163-3174. PubMed ID: 37382633
[TBL] [Abstract][Full Text] [Related]
9. TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance.
Yang Y; Kohler ME; Chien CD; Sauter CT; Jacoby E; Yan C; Hu Y; Wanhainen K; Qin H; Fry TJ
Sci Transl Med; 2017 Nov; 9(417):. PubMed ID: 29167392
[TBL] [Abstract][Full Text] [Related]
10. Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.
MacLeod DT; Antony J; Martin AJ; Moser RJ; Hekele A; Wetzel KJ; Brown AE; Triggiano MA; Hux JA; Pham CD; Bartsevich VV; Turner CA; Lape J; Kirkland S; Beard CW; Smith J; Hirsch ML; Nicholson MG; Jantz D; McCreedy B
Mol Ther; 2017 Apr; 25(4):949-961. PubMed ID: 28237835
[TBL] [Abstract][Full Text] [Related]
11. Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies.
Schwab RD; Bedoya DM; King TR; Levine BL; Posey AD
Methods Mol Biol; 2020; 2086():203-211. PubMed ID: 31707678
[TBL] [Abstract][Full Text] [Related]
12. Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
Palen K; Zurko J; Johnson BD; Hari P; Shah NN
Cytotherapy; 2021 Nov; 23(11):985-990. PubMed ID: 34538575
[TBL] [Abstract][Full Text] [Related]
13. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.
Ren J; Liu X; Fang C; Jiang S; June CH; Zhao Y
Clin Cancer Res; 2017 May; 23(9):2255-2266. PubMed ID: 27815355
[No Abstract] [Full Text] [Related]
14. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
Stenger D; Stief TA; Kaeuferle T; Willier S; Rataj F; Schober K; Vick B; Lotfi R; Wagner B; Grünewald TGP; Kobold S; Busch DH; Jeremias I; Blaeschke F; Feuchtinger T
Blood; 2020 Sep; 136(12):1407-1418. PubMed ID: 32483603
[TBL] [Abstract][Full Text] [Related]
15. CD8
Lee SY; Lee DH; Sun W; Cervantes-Contreras F; Basom RS; Wu F; Liu S; Rai R; Mirzaei HR; O'Steen S; Green DJ; Shadman M; Till BG
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38251688
[TBL] [Abstract][Full Text] [Related]
16. CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Barden M; Holzinger A; Velas L; Mezősi-Csaplár M; Szöőr Á; Vereb G; Schütz GJ; Hombach AA; Abken H
Front Immunol; 2023; 14():1110482. PubMed ID: 36817444
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors.
Lontos K; Wang Y; Joshi SK; Frisch AT; Watson MJ; Kumar A; Menk AV; Wang Y; Cumberland R; Lohmueller J; Carrizosa E; Boyerinas B; Delgoffe GM
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914208
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.
Sommer C; Boldajipour B; Kuo TC; Bentley T; Sutton J; Chen A; Geng T; Dong H; Galetto R; Valton J; Pertel T; Juillerat A; Gariboldi A; Pascua E; Brown C; Chin SM; Sai T; Ni Y; Duchateau P; Smith J; Rajpal A; Van Blarcom T; Chaparro-Riggers J; Sasu BJ
Mol Ther; 2019 Jun; 27(6):1126-1138. PubMed ID: 31005597
[TBL] [Abstract][Full Text] [Related]
19. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
20. Biomaterials in Chimeric Antigen Receptor T-Cell Process Development.
Cardle II; Cheng EL; Jensen MC; Pun SH
Acc Chem Res; 2020 Sep; 53(9):1724-1738. PubMed ID: 32786336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
